Epstein-Barr virus-positive primary brain lymphoma complicating immunoblastic lymphadenopathy.
A 54-year-old man developed primary brain lymphoma after immunosuppressive treatment for immunoblastic lymphadenopathy. The lymphoma cells were positive for the Epstein-Barr virus genome and had the surface phenotype of early B cells and a normal karyotype.
D001932:Brain Neoplasms / Q000209:etiology* / Q000382:microbiology; D002472:Cell Transformation, Viral; D004854:Herpesvirus 4, Human; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications* / Q000382:microbiology; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008223:Lymphoma / Q000209:etiology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged
D007166:Immunosuppressive Agents